Search
for
Sort by
Research 21
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Author response: The molecular basis for ANE syndrome revealed by the large ribosomal subunit processome interactome
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Teriflunomide in multiple sclerosis: an update
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Differential impact of environmental factors on systemic and localized autoimmunity
- Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations
- Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals
- OA08 Ocrelizumab in pregnancy in a patient with juvenile onset systemic lupus erythematosus
- Decision letter: The molecular basis for ANE syndrome revealed by the large ribosomal subunit processome interactome
- Identification of Epigenetic Regulator‐Associated Genes in Keloid Disease Through Integrated Bulk and Single‐Cell Transcriptomics With RT ‐ qPCR Validation
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning